Surgery · Northport, AL
NPI
1396779161
Since 2006
Specialty
Surgery
Code 208600000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1325 McFarland Blvd
Northport, AL, 35476
Phone (205) 926-2992
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
73,289 services
Medicare patients, 2024
112
Average age 73
Drug cost, 2024
$311K
452 prescriptions
Company payments, 2025
$322
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John O Waits was code 11045 (debridement), 239 times for 11 patients. In total John O Waits billed 73,289 services in 49 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 11045 Debridement | Facility | 239 | 11 | $17.93 | $4,286 |
| 11042 Debridement | Facility | 153 | 36 | $37.29 | $5,705 |
| 96365 Intravenous Infusion, Hydration | Office | 124 | 16 | $42.86 | $5,315 |
| 11043 Debridement | Facility | 99 | 28 | $102.49 | $10K |
| 11044 Debridement | Facility | 34 | 15 | $151.48 | $5,150 |
| 99213 Office E&M - Established | Facility | 18 | 11 | $45.23 | $814 |
| 99204 Office E&M - New | Facility | 13 | 13 | $96.96 | $1,260 |
By year: 2022 $697K for 71,099 services; 2023 $651K for 65,747 services; 2024 $1.1M for 73,289 services.
Medicare prescription drug claims, 2024
In 2024, the drug John O Waits prescribed most often to Medicare patients was Dalvance (Dalbavancin Hcl), with 48 prescriptions and refills. In total John O Waits wrote 452 Medicare prescriptions that cost $311K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalvance Dalbavancin Hcl | 48 | 48 | 11 | $248K |
| Daptomycin Generic | 42 | 42 | Under 11 | $45K |
| Dextrose In Water Dextrose 5 % In Water | 42 | 42 | Under 11 | $108 |
| Sodium Chloride 0.9 % Sodium Chloride | 41 | 41 | Under 11 | $232 |
| Doxycycline Hyclate Generic | 37 | 37 | 23 | $701 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 28 | 21 | $107 |
| Ceftriaxone Ceftriaxone Sodium | 27 | 27 | Under 11 | $4,946 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | 15 | $182 |
| Gentamicin Sulfate Generic | 21 | 21 | Under 11 | $752 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 12 | 12 | 12 | $207 |
Brand drugs: 143 claims; generic drugs: 309 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John O Waits $322 ($322 in general payments such as food, travel and fees) from 5 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Urgo Medical North America, LLC | 1 | $91.83 |
| BSN Medical Inc | 2 | $58.99 |
| Smith+Nephew, Inc. SNN | 1 | $24.78 |
| La Jolla Pharmaceutical Company | 1 | $21.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.